SCHEMBL18999940

SCHEMBL18999940

N#Cc1cc2c(N)c(C(O)N(c3ccccc3)c3ccccc3)sc2nc1N

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 8/20 0.52
MEN1 O00255 6/20 0.52
KMT2A Q03164 6/20 0.52
SMN1; SMN2 Q16637 4/20 0.52
KDM4E B2RXH2 4/20 0.52
RAB9A P51151 4/20 0.52
HTT P42858 1/20 0.52
ALDH1A1 P00352 5/20 0.46
RXFP1 Q9HBX9 3/20 0.46
NPC1 O15118 3/20 0.43
LMNA P02545 2/20 0.43
POLB P06746 2/20 0.42
GAA P10253 2/20 0.40
ADORA2A P29274 7/20 0.33
ADORA1 P30542 5/20 0.33
USP2 O75604 2/20 0.33
ALOX15 P16050 1/20 0.33
XBP1 P17861 1/20 0.33
HSD17B10 Q99714 1/20 0.33
NPSR1 Q6W5P4 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL425225 0.75 MAPT (0.66) MAPTMEN1KMT2ASMN1; SMN2KDM4E
SCHEMBL6251169 0.71 MAPT (0.70) MAPTMEN1KMT2ASMN1; SMN2KDM4E
SCHEMBL18819415 0.70 MAPT (0.59) MAPTMEN1KMT2ASMN1; SMN2KDM4E
SCHEMBL14955568 0.69 MAPT (0.74) MAPTMEN1KMT2ASMN1; SMN2KDM4E
SCHEMBL18537688 0.68 KDM4E (0.60) MAPTMEN1KMT2ASMN1; SMN2KDM4E
SCHEMBL19769220 0.66 MAPT (0.74) MAPTMEN1KMT2ASMN1; SMN2KDM4E
SCHEMBL18819408 0.66 MAPT (0.51) MAPTMEN1KMT2ASMN1; SMN2KDM4E
SCHEMBL18999975 0.65 KDM4E (0.56) MAPTMEN1KMT2ASMN1; SMN2KDM4E
SCHEMBL18537725 0.65 MAPT (0.76) MAPTMEN1KMT2ASMN1; SMN2KDM4E
SCHEMBL430440 0.63 MAPT (0.74) MAPTMEN1KMT2ASMN1; SMN2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3181568-A1 THIENOPYRIDINE DERIVATIVES FOR THE TREATMENT AND PREVENTION OF DENGUE VIRUS INFECTIONS Siga Technologies, Inc. (US) 2017-06-21 EP disclosed